Ferroptosis-IN-16
Ferroptosis-IN-16 (Compound 13l) is a specific inhibitor for ferroptosis with an EC50 of 0.7 nM and 0.9 nM in ES-2 cell and LX-2 cell. Ferroptosis-IN-16 ameliorates Acetaminophen -induced acute liver injury in mouse model, and exhibits good metabolic stability in mouse liver microsomes[1].
Product Specifications
UNSPSC
12352005
Target
Ferroptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ferroptosis-in-16.html
Smiles
C12=CC=CC=C1N=C3C(C=CC=C3C4=NC(C5=CC=CC(CN6CCCCC6)=C5)=NO4)=N2
Molecular Formula
C26H23N5O
Molecular Weight
421.49
References & Citations
[1]Wu Y, et al., Discovery of phenazine derivatives as a new class of non-classical ferroptosis inhibitors and efficacy evaluation on a mouse model of liver injury. Eur J Med Chem. 2025 Jan 15;282:117042.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472652-500 1x 500 µL
B7-H4 (Immuno-Inhibitory Protein) (B7H4/2652R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0158-500 1x 500 µL
Cytokeratin 17 (E3), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742298-500 1x 500 µL
Cytokeratin 8/18 (rKRT8.18/1346), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0257-100 1x 100 µL
Cytokeratin, HMW (AE-3), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details